Text Size

Prospective, Multicenter, Cross-Sectional Survey on Dry Eye Disease in Japan

Shimazaki J., Nomura Y., Numa S., Murase Y., Kakinoki K., Abe F., Kato Y., Okabe H., Kishimoto H., Yamada Y.

  • 2020
  • Advances in Therapy
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital, Ichikawa, Japan; Fujita Eye Clinic, Tokushima, Japan; Sakka Eye Clinic, Kitakyushu, Japan; Kasai Eye Clinic, Tokyo, Japan; Kakinoki Eye Clinic, Tokyo, Japan; Abe Eye Clinic, Oita, Japan; Sapporo Kato Eye Clinic, Sapporo, Japan; Heisei Eye Hospital, Sendai, Japan; Japan Medical Affairs, Development Management Department, Japan Business, Santen Pharmaceutical Co., Ltd., Osaka, Japan

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022